Wells Fargo’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31M | Buy |
|
|||||
|
2025
Q1 | $22.8M | Sell |
|
|||||
|
2024
Q4 | $26.9M | Buy |
|
|||||
|
2024
Q3 | $27.3M | Sell |
|
|||||
|
2024
Q2 | $27.1M | Buy |
|
|||||
|
2024
Q1 | $14.6M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Sell |
|
|||||
|
2023
Q3 | $12.3M | Buy |
|
|||||
|
2023
Q2 | $11.8M | Buy |
|
|||||
|
2023
Q1 | $12M | Buy |
|
|||||
|
2022
Q4 | $13.7M | Sell |
|
|||||
|
2022
Q3 | $15.4M | Buy |
|
|||||
|
2022
Q2 | $15.4M | Sell |
|
|||||
|
2022
Q1 | $17.9M | Buy |
|
|||||
|
2021
Q4 | $17.7M | Sell |
|
|||||
|
2021
Q3 | $79.8M | Buy |
|
|||||
|
2021
Q2 | $49.5M | Sell |
|
|||||
|
2021
Q1 | $57.6M | Buy |
|
|||||
|
2020
Q4 | $46.3M | Sell |
|
|||||
|
2020
Q3 | $33.9M | Sell |
|
|||||
|
2020
Q2 | $51.7M | Buy |
|
|||||
|
2020
Q1 | $5.01M | Buy |
|
|||||
|
2019
Q4 | $4.4M | Sell |
|
|||||
|
2019
Q3 | $5.47M | Sell |
|
|||||
|
2019
Q2 | $11.6M | Sell |
|
|||||
|
2019
Q1 | $40.5M | Sell |
|
|||||
|
2018
Q4 | $43.1M | Sell |
|
|||||
|
2018
Q3 | $60.3M | Sell |
|
|||||
|
2018
Q2 | $53.7M | Buy |
|
|||||
|
2018
Q1 | $51.1M | Sell |
|
|||||
|
2017
Q4 | $110M | Buy |
|
|||||
|
2017
Q3 | $85.5M | Sell |
|
|||||
|
2017
Q2 | $94.8M | Buy |
|
|||||
|
2017
Q1 | $40.5M | Sell |
|
|||||
|
2016
Q4 | $60M | Buy |
|
|||||
|
2016
Q3 | $2.64M | Sell |
|
|||||
|
2016
Q2 | $2.98M | Buy |
|
|||||
|
2016
Q1 | $2.54M | Sell |
|
|||||
|
2015
Q4 | $4.77M | Buy |
|
|||||
|
2015
Q3 | $2.72M | Sell |
|
|||||
|
2015
Q2 | $13.6M | Sell |
|
|||||
|
2015
Q1 | $27.7M | Sell |
|
|||||
|
2014
Q4 | $23.3M | Sell |
|
|||||
|
2014
Q3 | $24.4M | Sell |
|
|||||
|
2014
Q2 | $37M | Sell |
|
|||||
|
2014
Q1 | $44.1M | Sell |
|
|||||
|
2013
Q4 | $56.5M | Sell |
|
|||||
|
2013
Q3 | $44.3M | Sell |
|
|||||
|
2013
Q2 | $39.7M | Buy |
|